PCT vs. ACHV
PCT (PureCycle Technologies, Inc.) and ACHV (Achieve Life Sciences, Inc.) are both stocks. PCT operates in Pollution & Treatment Controls (Industrials), while ACHV operates in Biotechnology (Healthcare). Over the past 5 years, PCT returned -17.14%/yr vs -4.87%/yr for ACHV. At a 0.18 correlation, their price movements are largely independent.
Performance
PCT vs. ACHV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PCT achieves a -22.00% return, which is significantly lower than ACHV's 22.74% return.
PCT
- 1D
- -8.22%
- 1M
- -24.55%
- 6M
- -36.01%
- YTD
- -22.00%
- 1Y
- -56.07%
- 3Y*
- -13.44%
- 5Y*
- -17.14%
- 10Y*
- —
ACHV
- 1D
- -0.16%
- 1M
- 10.51%
- 6M
- 7.77%
- YTD
- 22.74%
- 1Y
- 162.93%
- 3Y*
- 4.67%
- 5Y*
- -4.87%
- 10Y*
- -44.21%
PCT vs. ACHV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PCT PureCycle Technologies, Inc. | -22.00% | -16.20% | 153.09% | -40.09% | -29.36% | -40.67% | 58.14% |
ACHV Achieve Life Sciences, Inc. | 22.74% | 41.19% | -14.56% | 68.16% | -68.51% | -3.95% | 6.64% |
Correlation
The correlation between PCT and ACHV is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jul 14, 2020 | 0.18 |
Fundamentals
PCT:
$1.34B
ACHV:
$626.22M
PCT:
-$1.24
ACHV:
-$0.99
PCT:
$10.90M
ACHV:
$0.00
PCT:
-$112.92M
ACHV:
-$111.00K
PCT:
-$117.00M
ACHV:
-$41.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PCT vs. ACHV — Risk / Return Rank
PCT
ACHV
PCT vs. ACHV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for PureCycle Technologies, Inc. (PCT) and Achieve Life Sciences, Inc. (ACHV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PCT | ACHV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.47 | ||
| Sortino ratioReturn per unit of downside risk | -3.51 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.34 | -0.44 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 3.01 | -3.81 |
| Martin ratioReturn relative to average drawdown | -1.31 | 8.61 | -9.91 |
Loading charts...
Drawdowns
PCT vs. ACHV - Drawdown Comparison
The maximum PCT drawdown since its inception was -92.66%, smaller than the maximum ACHV drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for PCT and ACHV.
Loading charts...
Drawdown Indicators
| PCT | ACHV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.66% | -100.00% | +7.34% |
Max Drawdown (1Y)Largest decline over 1 year | -70.09% | -54.55% | -15.54% |
Max Drawdown (3Y)Largest decline over 3 years | -79.73% | -66.30% | -13.43% |
Max Drawdown (5Y)Largest decline over 5 years | -85.71% | -80.11% | -5.60% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.91% | — |
Current DrawdownCurrent decline from peak | -79.50% | -99.99% | +20.49% |
Average DrawdownAverage peak-to-trough decline | -63.33% | -83.88% | +20.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.96% | 19.01% | +23.95% |
Volatility
PCT vs. ACHV - Volatility Comparison
PureCycle Technologies, Inc. (PCT) and Achieve Life Sciences, Inc. (ACHV) have volatilities of 19.25% and 19.63%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PCT | ACHV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.25% | 19.63% | -0.38% |
Volatility (6M)Calculated over the trailing 6-month period | 62.52% | 68.27% | -5.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.60% | 92.61% | -12.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 92.28% | 74.35% | +17.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.95% | 91.51% | -0.56% |
Dividends
PCT vs. ACHV - Dividend Comparison
Neither PCT nor ACHV has paid dividends to shareholders.
Financials
PCT vs. ACHV - Financials Comparison
This section allows you to compare key financial metrics between PureCycle Technologies, Inc. and Achieve Life Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PCT and ACHV have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACHV has higher volatility (19.63%) compared to PCT (19.25%). In terms of maximum drawdown, PCT dropped -92.66% vs ACHV's -100.00%.
ACHV currently has the higher Sharpe Ratio (1.77 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PCT and ACHV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer